Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of Tier 2 LC-MRM-MS protein quantification methods for liquid biopsies.
Diederiks N, Ravensbergen CJ, Treep M, van Wezel M, Kuruc M, Renee Ruhaak L, Tollenaar RAEM, Cobbaert CM, van der Burgt YEM, Mesker WE. Diederiks N, et al. J Mass Spectrom Adv Clin Lab. 2022 Dec 23;27:49-55. doi: 10.1016/j.jmsacl.2022.12.007. eCollection 2023 Jan. J Mass Spectrom Adv Clin Lab. 2022. PMID: 36619217 Free PMC article.
Serum N-glycan profiles differ for various breast cancer subtypes.
Vreeker GCM, Vangangelt KMH, Bladergroen MR, Nicolardi S, Mesker WE, Wuhrer M, van der Burgt YEM, Tollenaar RAEM. Vreeker GCM, et al. Glycoconj J. 2021 Jun;38(3):387-395. doi: 10.1007/s10719-021-10001-3. Epub 2021 Apr 20. Glycoconj J. 2021. PMID: 33877489 Free PMC article.
Dried blood spot N-glycome analysis by MALDI mass spectrometry.
Vreeker GCM, Bladergroen MR, Nicolardi S, Mesker WE, Tollenaar RAEM, van der Burgt YEM, Wuhrer M. Vreeker GCM, et al. Talanta. 2019 Dec 1;205:120104. doi: 10.1016/j.talanta.2019.06.104. Epub 2019 Jun 29. Talanta. 2019. PMID: 31450448 Free article.
N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.
Holst S, Deuss AJ, van Pelt GW, van Vliet SJ, Garcia-Vallejo JJ, Koeleman CA, Deelder AM, Mesker WE, Tollenaar RA, Rombouts Y, Wuhrer M. Holst S, et al. Mol Cell Proteomics. 2016 Jan;15(1):124-40. doi: 10.1074/mcp.M115.051235. Epub 2015 Nov 4. Mol Cell Proteomics. 2016. PMID: 26537799 Free PMC article.
Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium.
Howat WJ, Blows FM, Provenzano E, Brook MN, Morris L, Gazinska P, Johnson N, McDuffus LA, Miller J, Sawyer EJ, Pinder S, van Deurzen CH, Jones L, Sironen R, Visscher D, Caldas C, Daley F, Coulson P, Broeks A, Sanders J, Wesseling J, Nevanlinna H, Fagerholm R, Blomqvist C, Heikkilä P, Ali HR, Dawson SJ, Figueroa J, Lissowska J, Brinton L, Mannermaa A, Kataja V, Kosma VM, Cox A, Brock IW, Cross SS, Reed MW, Couch FJ, Olson JE, Devillee P, Mesker WE, Seyaneve CM, Hollestelle A, Benitez J, Perez JI, Menéndez P, Bolla MK, Easton DF, Schmidt MK, Pharoah PD, Sherman ME, García-Closas M. Howat WJ, et al. J Pathol Clin Res. 2014 Dec 4;1(1):18-32. doi: 10.1002/cjp2.3. eCollection 2015 Jan. J Pathol Clin Res. 2014. PMID: 27499890 Free PMC article.
The stromal part of adenocarcinomas of the oesophagus: does it conceal targets for therapy?
Courrech Staal EF, Wouters MW, van Sandick JW, Takkenberg MM, Smit VT, Junggeburt JM, Spitzer-Naaykens JM, Karsten T, Hartgrink HH, Mesker WE, Tollenaar RA. Courrech Staal EF, et al. Eur J Cancer. 2010 Mar;46(4):720-8. doi: 10.1016/j.ejca.2009.12.006. Epub 2010 Jan 13. Eur J Cancer. 2010. PMID: 20044247
There were no significant differences in patient, tumour and treatment characteristics between the two groups, except for M status (M1a) and radicality of resection. The (disease-free) survival in the TSR high group was significantly better than in the TSR low group. ...
There were no significant differences in patient, tumour and treatment characteristics between the two groups, except for M status (M …
12 results